Regulations/FDA CSA/Updates & Assets
Updates & Assets · FDA CSA

Updates & Assets for FDA CSA.

This page is the living shelf for validated assets, weekly signals, revision notes, and future public tools. Nothing here should look published-ready until the source trail and boundary have been checked.

Source basis: Computer Software Assurance for Production and Quality System SoftwareUse: evidence-readinessBoundary: not legal advice
FDA CSA TRACE FDA CSA FINAL GUIDQMSR TERMINOLOGYPRODUCTION SOFTWQUALITY MANAGEME
/ Asset shelf

Public assets attach only after source validation.

FDA CSA
Asset 01

CSA assessment worksheet

Future asset for FDA CSA; publish only after source check, date check, boundary review, and revision note.

Asset 02

risk-to-assurance ladder

Future asset for FDA CSA; publish only after source check, date check, boundary review, and revision note.

Asset 03

unscripted testing record

Future asset for FDA CSA; publish only after source check, date check, boundary review, and revision note.

Asset 04

objective evidence capture form

Future asset for FDA CSA; publish only after source check, date check, boundary review, and revision note.

Asset 05

change-impact worksheet

Future asset for FDA CSA; publish only after source check, date check, boundary review, and revision note.

/ Watchlist

Updates must show what changed.

revision protocol
Protocol 01

Source revision

Record date, source URL, affected pages, and what interpretation changed.

Protocol 02

Weekly signal

Only promote signals that alter operating decisions, evidence expectations, market movement, or governance work.

Protocol 03

Checklist release

Each checklist needs version, source links, evidence fields, public-safe disclaimer, and review boundary.

Protocol 04

Retirement

Outdated pages should be marked, archived, or redirected without deleting the trace.